Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2011
Source ID
10.1016/j.bbadis.2011.05.007

Entities

People

  • Bo Feng
  • Fengjing Liu
  • Hua Wang
  • Ji-fan Hu
  • Junli Xue
  • Lei Xu
  • Xinfeng Yan

Organizations

  • California Institute for Regenerative Medicine
  • National Institutes of Health
  • United States Department of Defense